Novartis wins USFDA approval for first PI3K inhibitor for breast cancer Farhat Nasim27 May 2019 6:10 PM ISTThe drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to...
Cigna caps insulin prices at $25 for 30 days Medical Dialogues Bureau4 April 2019 9:00 AM ISTCigna, which bought pharmacy benefits manager Express Scripts last year, said it was partnering with insulin manufacturers to lower copayments to $25...
AstraZeneca gets EU nod to diabetes drug Forxiga Medical Dialogues Bureau27 March 2019 2:55 PM ISTFarxiga or Forxiga, as the drug is known outside the United States, is one of AstraZeneca's top ten drugs by sales. It generated $1.39 billion in 2018...
Setback: USFDA rejects Sanofi, Lexicon Sotagliflozin for type 1 diabetes Farhat Nasim24 March 2019 9:45 AM ISTThe decision comes about two months after an FDA advisory panel failed to reach a consensus over whether the once-daily oral drug, sotagliflozin,...
Biocon gets JDRF support for global study on diabetes molecule Ruby Khatun Khatun7 Sept 2017 10:02 AM ISTNew Delhi: Biotechnology major Biocon on Thursday said it has received financial support from the US-based JDRF for a global clinical study of its...
Biocon, Mylan Present Clinical Data on Insulin Glargine at American Diabetes Associations 77th Scientific Sessions Ruby Khatun Khatun12 Jun 2017 11:29 AM ISTMylan N.V. and Biocon Ltd. announced the presentation of new data from the insulin glargine clinical program, including the INSTRIDE studies at the...
